NCT07576699

CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2026-11-01Est. Completion: 2028-06-30

Enrollment target: 12 participants

Contact

Graft-versus-host Disease (GVHD)

The purpose of this study is to assess Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacro…

Palo Alto, United StatesEst. completion Jan 17, 2031

Acute Graft vs Host Disease

Graft-versus-host disease (GVHD) is a common severe complication and a primary cause of mortality following allogeneic h…

Hefei, ChinaEst. completion Jun 10, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.